Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.
Jun 29, 2020
0
177
Italy saw its first drop Saturday in the number of patients receiving intensive care treatment for the coronavirus that had stretched the Mediterranean country's world-class healthcare system to breaking point.
Apr 4, 2020
1
3
Most people know about the painkiller paracetamol, commonly used against headaches and ingested orally.
Mar 25, 2020
0
7
In an article published recently in Microgravity, a Nature journal, researchers at Rensselaer Polytechnic Institute demonstrate a unique method for studying the mechanisms behind the formation of amyloid fibrils associated ...
Jan 28, 2020
0
242
Ophthalmologist and retinal surgeon Dimitra Skondra, MD, Ph.D., knows that developing any new treatment can be fraught with false hopes and unexpected setbacks. She is cautiously optimistic, however, that a new method she ...
Oct 24, 2019
0
58
Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision Science and Technology.
May 7, 2019
0
4
New research shows that hypnosis can reduce pain by up to 42% and may offer a genuine alternative to painkillers.
Apr 25, 2019
1
105
(HealthDay)—Osteoporosis is a threat to many women, especially after menopause. But the lead up to weak, brittle bones can start much earlier in life.
Feb 22, 2019
0
0
(HealthDay)—An expanded recall of ibuprofen oral suspension drops that may contain higher-than-specified levels of ibuprofen that could harm infants' kidneys has been announced by Tris Pharma, Inc.
Jan 31, 2019
0
0
If you've ever had to work in a draughty office, warehouse or classroom, you've probably been tempted to keep your coat on inside. And you were probably also advised against it because you wouldn't "feel the benefit" when ...
Dec 28, 2018
0
10
